Enhabit, Inc. (EHAB)
| Market Cap | 706.91M +75.3% |
| Revenue (ttm) | 1.06B +3.2% |
| Net Income | -3.20M |
| EPS | -0.06 |
| Shares Out | 51.23M |
| PE Ratio | n/a |
| Forward PE | 19.44 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,382,540 |
| Open | 13.79 |
| Previous Close | 13.79 |
| Day's Range | 13.79 - 13.81 |
| 52-Week Range | 6.47 - 14.22 |
| Beta | 0.96 |
| Analysts | Hold |
| Price Target | 13.84 (+0.29%) |
| Earnings Date | May 7, 2026 |
About EHAB
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s ... [Read more]
Financial Performance
In 2025, Enhabit's revenue was $1.06 billion, an increase of 2.44% compared to the previous year's $1.03 billion. Losses were -$4.60 million, -97.06% less than in 2024.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for EHAB stock is "Hold." The 12-month stock price target is $13.84, which is an increase of 0.29% from the latest price.
News
Enhabit Home Health & Hospice Announces New Chief Executive Officer
DALLAS--(BUSINESS WIRE)--Enhabit, Inc., a leading home health and hospice provider, today announced that Dale Clift has been appointed president and CEO, following the successful completion of the com...
Enhabit Quarterly report: Q1 2026
Enhabit has published its Q1 2026 quarterly earnings report on May 7, 2026.
Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders...
Enhabit Proxy statement: Proxy filing
Enhabit filed a proxy statement on April 14, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy filing
Enhabit filed a proxy statement on March 30, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on March 5, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Reports Fourth Quarter 2025 Financial Results
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. “Our fourth q...
Enhabit Annual report: Q4 2025
Enhabit has published its Q4 2025 annual report on March 4, 2026.
Enhabit Earnings release: Q4 2025
Enhabit released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.
Enhabit Slides: Q4 2025
Enhabit has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 26, 2026, providing details for shareholder voting and corporate governance matters.
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Enhabit, Inc. (EHAB)
Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("En...
Enhabit to be Acquired by Kinderhook Industries
DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinder...
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Proxy statement: Proxy Filing
Enhabit filed a proxy statement on February 23, 2026, providing details for shareholder voting and corporate governance matters.
Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year en...
Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims fo...
Enhabit Transcript: Bank of America Home Care Conference
Final home health rate cuts were less severe than expected, supporting profitability and investment plans for 2026. Strategic focus includes disciplined M&A, payer innovation, and operational efficiency, with mid- to high-single digit growth targeted for both home health and hospice.
Enhabit Slides: Bank of America Home Care Conference
Enhabit has posted slides in relation to its latest quarterly earnings report, which was published on December 9, 2025.
Enhabit Announces Participation in Bank of America Home Care Conference 2025
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Bank of America Home Care Conference 2025. Enhabit's ...
Enhabit Transcript: UBS Global Healthcare Conference 2025
Hospice outperformed expectations, while home health growth and margin depend on the final CMS rule. Operational pilots and payer strategies are offsetting regulatory risks, and deleveraging has improved financial flexibility. Litigation remains ongoing.
Enhabit Earnings Call Transcript: Q3 2025
Q3 saw strong revenue and EBITDA growth, led by record hospice performance and improved home health metrics. Guidance for full-year revenue, EBITDA, and free cash flow was raised, while leverage and costs improved. Strategic initiatives are in place to address upcoming CMS rate changes.
Enhabit Quarterly report: Q3 2025
Enhabit has published its Q3 2025 quarterly earnings report on November 6, 2025.
Enhabit Earnings release: Q3 2025
Enhabit released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.